Evidence map›Paper›PMID 30804130›Full record

ArticleIn vivo (Athens, Greece)

Breast Cancer in Lean Postmenopausal Women Might Have Specific Pathological Features.

Toshitaka Uomori, Yoshiya Horimoto, Atsushi Arakawa, Kotaro Iijima, Mitsue Saito

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Toshitaka UomoriDeartment of Breast Oncology, Juntendo University School of Medcine, Tokyo, Japan.
Yoshiya HorimotoDeartment of Breast Oncology, Juntendo University School of Medcine, Tokyo, Japan yoshiyahorimoto@hotmail.com.
Atsushi ArakawaDeartment of Human Pathology, Juntendo University School of Medcine, Tokyo, Japan.
Kotaro IijimaDeartment of Breast Oncology, Juntendo University School of Medcine, Tokyo, Japan.
Mitsue SaitoDeartment of Breast Oncology, Juntendo University School of Medcine, Tokyo, Japan.
Juntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe rate of obesity, an independent risk factor for breast cancer in post-menopausal women, is quite low in Japan, indicating breast cancer in lean women to be more common in the Japanese than in Westerners. However, biological characteristics of such breast cancers have not been adequately investigated. PATIENTS AND

methodsWe retrospectively investigated clinicopathological breast cancer features of 566 postmenopausal Japanese women, who underwent curative surgery, in relation to patient physique based on the body mass index.

resultsThere were no differences in several factors examined such as tumour size according to patient physique. On the other hand, mean values of the Ki67 labelling index were significantly higher in lean compared to obese patients (p=0.027). Likewise, HER2-positive tumours were more often observed in lean patients (p=0.051).

conclusionLean postmenopausal women had more aggressive tumours, apparently contradicting the widely held view for breast cancer in obese women.

Indexed as

Body Mass IndexAdultAgedBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleHumansJapanKi-67 AntigenMiddle AgedObesityPostmenopauseReceptors, EstrogenRisk FactorsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKi-67 AntigenMKI67 protein, humanReceptors, EstrogenBreast cancerlean womenobesitypostmenopausal

Identifiers

PMID30804130
PMCPMC6506305
OpenAlexW2917239103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.